From Our Partners
Sunday, June 26, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

USAMRIID Contract for Infectious Disease Training in Uganda

by Global Biodefense Staff
October 29, 2014

USAMRIID Training in UgandaThe U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) has announced intentions to award a contract with Infectious Diseases Institute Limited (IDI) in Kampala, Uganda for purchase of services involving logistical, professional and administrative support for conduct of clinical research and training on select biological agents in Uganda, Kenya and Tanzania.

The effort will support recognition, diagnosis and management of biological casualties training for Ugandan health care providers. The award will be for a base year and 4 optional years of service.

IDI has the unique experience required to leverage their experience in working with key Ugandan government, professional and academician officials to assist USAMRIID with designing and delivering a self-sustaining training product tailored specifically to the needs of the Ugandan health care professionals.

IDI is also co-located with the Makerere University School of Medicine, which is critical as this is the key training site for training of trainers and the school must approve the training curriculum.

The contract is being awarded on a sole-source basis, “given the substantial time required for any other company to establish themselves in the highly political and cultural atmosphere currently in place in the Ugandan health care systems.”

The contract is being managed by the U.S. Army Medical Research Acquisition Activity.

From Our Partners
Tags: AwardsUSAMRIID

Related Posts

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
Biosecurity

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies

June 14, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
masked medical laboratory technician waits on samples to process in a biocontainment lab
Biosecurity

Design Phase Kicks Off for New $750M Wadsworth Public Health Laboratory

May 1, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC